INDEGENE
Quarterly Results Analysis [Sep2025]
INDEGENE Quarterly Results
| Consolidated | Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹804 Cr | ₹761 Cr | ₹756 Cr | ₹720 Cr | ₹687 Cr | ₹677 Cr | ₹673 Cr | ₹673 Cr |
| Expenses | ₹664 Cr | ₹606 Cr | ₹608 Cr | ₹589 Cr | ₹561 Cr | ₹548 Cr | ₹534 Cr | ₹525 Cr |
| Operating Income | ₹141 Cr | ₹155 Cr | ₹148 Cr | ₹132 Cr | ₹126 Cr | ₹129 Cr | ₹139 Cr | ₹149 Cr |
| Other Income | ₹20 Cr | ₹22 Cr | ₹26 Cr | ₹38 Cr | ₹21 Cr | ₹23 Cr | ₹23 Cr | ₹13 Cr |
| Interest | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
| Depreciation | ₹23 Cr | ₹22 Cr | ₹21 Cr | ₹20 Cr | ₹19 Cr | ₹20 Cr | ₹19 Cr | ₹18 Cr |
| Profit Before Tax | ₹133 Cr | ₹152 Cr | ₹149 Cr | ₹146 Cr | ₹124 Cr | ₹120 Cr | ₹134 Cr | ₹132 Cr |
| Profit After Tax | ₹102 Cr | ₹116 Cr | ₹118 Cr | ₹110 Cr | ₹92 Cr | ₹88 Cr | ₹95 Cr | ₹99 Cr |
| EPS | ₹4.25 | ₹4.86 | ₹4.91 | ₹4.59 | ₹3.84 | ₹3.66 | ₹4.27 | ₹4.45 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| INDEGENE | -0.5% | -6.1% | -23.2% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.6% | 6% | -2% |
| DIVIS LABORATORIES | -0.7% | -1.9% | 12.3% |
| CIPLA | -0.4% | -3.4% | 0.8% |
| TORRENT PHARMACEUTICALS | -0.8% | 7.4% | 21.2% |
| DR REDDYS LABORATORIES | 1.2% | 0.3% | -1.5% |
| MANKIND PHARMA | -2.2% | -9.4% | -14.6% |
| ZYDUS LIFESCIENCES | -2.4% | -5.7% | -1.7% |
| LUPIN | 0.6% | 5% | -1.7% |
INDEGENE Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 5.70 % |
| Y-o-Y | 17.09 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Sep2025 | ₹804 Cr | 5.70 | |
| Jun2025 | ₹761 Cr | 0.69 | |
| Mar2025 | ₹756 Cr | 4.89 | |
| Dec2024 | ₹720 Cr | 4.89 | |
| Sep2024 | ₹687 Cr | 1.52 | |
| Jun2024 | ₹677 Cr | 0.52 | |
| Mar2024 | ₹673 Cr | -0.06 | |
| Dec2023 | ₹673 Cr | - | |
INDEGENE Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -9.47 % |
| Y-o-Y | 11.50 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Sep2025 | ₹141 Cr | -9.47 | |
| Jun2025 | ₹155 Cr | 5.29 | |
| Mar2025 | ₹148 Cr | 11.91 | |
| Dec2024 | ₹132 Cr | 4.52 | |
| Sep2024 | ₹126 Cr | -2.17 | |
| Jun2024 | ₹129 Cr | -7.07 | |
| Mar2024 | ₹139 Cr | -6.85 | |
| Dec2023 | ₹149 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -14.36 % |
| Y-o-Y | -4.79 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Sep2025 | 17.48% | -14.36 | |
| Jun2025 | 20.41% | 4.56 | |
| Mar2025 | 19.52% | 6.67 | |
| Dec2024 | 18.3% | -0.33 | |
| Sep2024 | 18.36% | -3.62 | |
| Jun2024 | 19.05% | -7.57 | |
| Mar2024 | 20.61% | -6.78 | |
| Dec2023 | 22.11% | - | |
INDEGENE Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -12.29 % |
| Y-o-Y | 11.34 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Sep2025 | ₹102 Cr | -12.29 | |
| Jun2025 | ₹116 Cr | -1.02 | |
| Mar2025 | ₹118 Cr | 7.20 | |
| Dec2024 | ₹110 Cr | 19.63 | |
| Sep2024 | ₹92 Cr | 4.56 | |
| Jun2024 | ₹88 Cr | -7.49 | |
| Mar2024 | ₹95 Cr | -4.05 | |
| Dec2023 | ₹99 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -16.99 % |
| Y-o-Y | -4.87 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Sep2025 | 12.7 % | -16.99 | |
| Jun2025 | 15.3 % | -1.67 | |
| Mar2025 | 15.56 % | 2.17 | |
| Dec2024 | 15.23 % | 14.08 | |
| Sep2024 | 13.35 % | 3.01 | |
| Jun2024 | 12.96 % | -8.02 | |
| Mar2024 | 14.09 % | -3.95 | |
| Dec2023 | 14.67 % | - | |
INDEGENE Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -12.55 % |
| Y-o-Y | 10.68 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Sep2025 | ₹4.25 | -12.55 | |
| Jun2025 | ₹4.86 | -1.02 | |
| Mar2025 | ₹4.91 | 6.97 | |
| Dec2024 | ₹4.59 | 19.53 | |
| Sep2024 | ₹3.84 | 4.92 | |
| Jun2024 | ₹3.66 | -14.29 | |
| Mar2024 | ₹4.27 | -4.04 | |
| Dec2023 | ₹4.45 | - | |
You may also like the below Video Courses